²»Á¼Ñо¿Ëù

Modulate gene activity in human iPSC-derived cells with a set of CRISPR-ready tools for gene knockout, activation, and interferenc...

Adding New Visualisation Functionality to Human iPSC-derived Cell Types

The European Patent Office (EPO) upholds ²»Á¼Ñо¿Ëù's patent for its dual genomic safe harbour technology, opti-oxâ„¢, securing the bro...

²»Á¼Ñо¿Ëù's ioSensory Neurons pain research was selected for presentation at SfN’s Neuroscience 2024 press conference.

²»Á¼Ñо¿Ëù Wins Honours for Innovation in Synthetic Biology and Exceptional Business Growth.

²»Á¼Ñо¿Ëù appoints new Chief Financial Officer, Przemek Obloj

²»Á¼Ñо¿Ëù launches panel of 16 neurodegenerative disease models for research and drug discovery in Alzheimer’s and Parkinson’s disea...

²»Á¼Ñо¿Ëù launches ioAstrocytes, advancing how scientists can model the human brain.